Санкт-Петербургский государственный педиатрический медицинский университет — старейшее педиатрическое высшее учебное заведение в мире.

During the past decade, St. Petersburg Clinical Hospital of RAS conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. Petersburg Clinical Hospital of RAS" are "Cancer" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "St. Petersburg Clinical Hospital of RAS" in a lesser frequency.

Most popular intervention types in "St. Petersburg Clinical Hospital of RAS" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "Finerenone (BAY94-8862)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Petersburg Clinical Hospital of RAS" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "St. Petersburg Clinical Hospital of RAS". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in St. Petersburg Clinical Hospital of RAS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Petersburg Clinical Hospital of RAS, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".